Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
Jane E. Minturn(St Nicholas Hospital), John M. Maris(Children's Hospital of Philadelphia), Katherine K. Matthay(University of California System), Edward T. Hellriegel, Susan Groshen(USC Norris Comprehensive Cancer Center), Suzanne Shusterman(Dana-Farber Cancer Institute), Judith G. Villablanca(University of Southern California), Gregory A. Yanik(University of Michigan), Debra M. Bensen-Kennedy, Garrett M. Brodeur(Children's Hospital of Philadelphia), Audrey E. Evans(Purdue University West Lafayette), Julie R. Park(Seattle Children's Hospital)
Cited by 98
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670